Molecular Theranostics, LLC (MT) was formed in January 2014 in the state of Ohio. Molecular Theranostics is an early stage biotechnology company with a focus on novel imaging technologies. The technologies in the pipelines will address the unmet clinical needs for early detection, risk-stratification, and active surveillance of aggressive cancers and non-invasive assessment of the efficacy of cancer therapies.